BUDA (NYSEAMERICAN:BUDA) Stock Picked Up by Analysts at Roth Capital

Analysts at Roth Capital started coverage on shares of BUDA (NYSEAMERICAN:BUDA – Get Free Report) in a research report issued to clients and investors on Monday, Marketbeat Ratings reports. The firm set a “buy” rating and a $12.00 price target on the stock. Roth Capital’s target price would indicate a potential upside of 52.09% from the company’s current price.

BUDA Price Performance

BUDA traded down $0.07 during midday trading on Monday, hitting $7.89. 21,189 shares of the company’s stock traded hands, compared to its average volume of 24,005. The stock’s fifty day simple moving average is $8.20 and its 200-day simple moving average is $8.93. BUDA has a one year low of $6.25 and a one year high of $12.00.

BUDA (NYSEAMERICAN:BUDA – Get Free Report) last posted its earnings results on Friday, August 14th. The company reported $0.04 earnings per share (EPS) for the quarter. The business had revenue of $4.51 million during the quarter.

BUDA Company Profile

(Get Free Report)

Buda Juice, Inc (NYSE American: BUDA) is a beverage company focused on producing and selling organic, cold-pressed juice products. Its offerings are designed to provide convenient, ready-to-consume beverages made from fruit, vegetables and other plant-based ingredients.

The company’s product portfolio includes cold-pressed juice shots and related functional beverage products, with formulations intended to support wellness and everyday nutrition. Buda Juice products are marketed through retail, natural and specialty food channels, as well as other distribution outlets.

Buda Juice serves consumers seeking refrigerated, minimally processed and plant-based beverage options.

Featured Articles

Receive News & Ratings for BUDA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BUDA and related companies with MarketBeat.com's FREE daily email newsletter.